The weight loss drug Mounjaro has been approved for sale in Hong Kong by Li Lai.

On October 28, Janssen Pharmaceuticals announced that it has obtained approval from the Hong Kong SAR government to sell its Tirzepatide injection (brand name: Mounjaro) in a device called Kwikpen (pre-filled injection pen) for long-term weight management and type 2 diabetes. Janssen expects to start selling this weight loss medication in Hong Kong as early as the end of this year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)